Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Editorial

Revolutionizing the World of Pharmaceuticals: Unleashing the Game-Changing Power of 3D Printing

Author(s): Abhishek Chahuan, Abhishek Verma, Devank Shekho, Ritika Mishra and Ankit Awasthi*

Volume 25, Issue 8, 2024

Published on: 06 May, 2024

Page: [513 - 516] Pages: 4

DOI: 10.2174/0113894501304163240429081741

Price: $65

Next »
[1]
Jandyal A, Chaturvedi I, Wazir I, Raina A, Ul Haq MI. 3D printing – A review of processes, materials and applications in industry 4.0. Sustainable Operations and Computers 2022; 3: 33-42.
[http://dx.doi.org/10.1016/j.susoc.2021.09.004]
[2]
Wang S, Chen X, Han X, et al. A review of 3D printing technology in pharmaceutics: technology and applications, now and future. Pharmaceutics 2023; 15(2): 416.
[http://dx.doi.org/10.3390/pharmaceutics15020416] [PMID: 36839738]
[3]
Gross BC, Erkal JL, Lockwood SY, Chen C, Spence DM. Evaluation of 3D printing and its potential impact on biotechnology and the chemical sciences. Anal Chem 2014; 86(7): 3240-53.
[http://dx.doi.org/10.1021/ac403397r] [PMID: 24432804]
[4]
Choonara YE, du Toit LC, Kumar P, Kondiah PPD, Pillay V. 3D-printing and the effect on medical costs: a new era? Expert Rev Pharmacoecon Outcomes Res 2016; 16(1): 23-32.
[http://dx.doi.org/10.1586/14737167.2016.1138860] [PMID: 26817398]
[5]
Griffey J. The types of 3-D printing. Libr Technol Rep 2014; 50(5): 8-12.
[6]
Goole J, Amighi K. 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. Int J Pharm 2016; 499(1-2): 376-94.
[http://dx.doi.org/10.1016/j.ijpharm.2015.12.071] [PMID: 26757150]
[7]
Ranjan R, Kumar D, Kundu M, Chandra Moi S. A critical review on Classification of materials used in 3D printing process. Mater Today Proc 2022; 61: 43-9.
[http://dx.doi.org/10.1016/j.matpr.2022.03.308]
[8]
Trenfield SJ, Awad A, Madla CM, et al. Shaping the future: recent advances of 3D printing in drug delivery and healthcare. Expert Opin Drug Deliv 2019; 16(10): 1081-94.
[http://dx.doi.org/10.1080/17425247.2019.1660318] [PMID: 31478752]
[9]
Mirza MA, Iqbal Z. 3D printing in pharmaceuticals: Regulatory perspective. Curr Pharm Des 2019; 24(42): 5081-3.
[http://dx.doi.org/10.2174/1381612825666181130163027] [PMID: 30963960]
[10]
Ricles LM, Coburn JC, Di Prima M, Oh SS. Regulating 3D-printed medical products. Sci Transl Med 2018; 10(461): eaan6521.
[http://dx.doi.org/10.1126/scitranslmed.aan6521] [PMID: 30282697]
[11]
Shah J, Snider B, Clarke T, Kozutsky S, Lacki M, Hosseini A. Large-scale 3D printers for additive manufacturing: design considerations and challenges. Int J Adv Manuf Technol 2019; 104(9-12): 3679-93.
[http://dx.doi.org/10.1007/s00170-019-04074-6]
[12]
El-Sayegh S, Romdhane L, Manjikian S. A critical review of 3D printing in construction: benefits, challenges, and risks. Arch Civ Mech Eng 2020; 20(2): 34.
[http://dx.doi.org/10.1007/s43452-020-00038-w]
[13]
Neely EL. The risks of revolution: Ethical dilemmas in 3D printing from a US perspective. Sci Eng Ethics 2016; 22(5): 1285-97.
[http://dx.doi.org/10.1007/s11948-015-9707-4] [PMID: 26387090]
[14]
Khosravani MR, Reinicke T. On the environmental impacts of 3D printing technology. Appl Mater Today 2020; 20100689.
[http://dx.doi.org/10.1016/j.apmt.2020.100689]
[15]
Beer N, Hegger I, Kaae S, et al. Scenarios for 3D printing of personalized medicines - A case study. Exploratory Research in Clinical and Social Pharmacy 2021; p. 4100073.
[http://dx.doi.org/10.1016/j.rcsop.2021.100073] [PMID: 35479838]
[16]
Ning X, Liu T, Wu C, Wang C. 3D printing in construction: current status, implementation hindrances, and development agenda. Adv Civ Eng 2021; 2021: 1-12.
[http://dx.doi.org/10.1155/2021/6665333]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy